Menopausal women suffering from post-menopausal discomfort Nutritional, Metabolic, Endocrine
Conditions
Interventions
A randomized, double-blind, placebo-controlled clinical trial in 64 women with postmenopausal dysfunction, was performed. The women who completed the study (n = 64), after an interview, signed an info
Sponsors
IRC-FSH -Magna Graecia University of Catanzaro
Eligibility
Sex/Gender
Female
Age
48 Years to 56 Years
Inclusion criteria
Inclusion criteria: 1. Postmenopausal women, with a minimum of 12 months of amenorrhea and a follicle-stimulating hormone level above 30 mIU/mL 2. Sexually active life 3. A stable partner 4. Postmenopausal sexual dysfunction
Exclusion criteria
Exclusion criteria: Women with hormonal therapy, diabetes, cognitive disorders, hormone-dependent tumors, psychiatric disease, liver diseases (except prior cholecystectomy), renal disease, cardiovascular disease, and those who used drugs that decrease sexual desire
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amelioration of Sexual behavior assessed by Sexual Quotient—female version (SQ-F) and the Female Intervention Efficacy Index (FIEI) questionnaires at time 0 and at 90 days of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation at time 0 and at 90 days of treatment: 1. Onset of menopause signs measured using Sexual Quotient—female version (SQ-F) and the Female Intervention Efficacy Index (FIEI) questionnaires 2. Plasma free radicals measured using blood test 3. Fat Mass (BMI assessment) measured using height (m) and weight (kg) 4. Platelet aggregation measured using platelet samples | — |
Countries
Italy
Contacts
Public ContactRoberta;Vincenzo Macrì;Mollace
;
Outcome results
None listed